Anzeige
Mehr »
Dienstag, 01.09.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40C39 | ISIN: US5049221055 | Ticker-Symbol: N6B
Tradegate
01.09.26 | 07:32
294,00 Euro
+2,08 % +6,00
Branche
Sonstige Technologie
Aktienmarkt
USA 500
1-Jahres-Chart
LABCORP HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
LABCORP HOLDINGS INC 5-Tage-Chart
RealtimeGeldBriefZeit
286,00290,0010:54
286,00294,0010:50

Aktuelle News zur LABCORP Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoLiving Security: Human Risk Management Leaders from Reveal Risk, Bayer, and Labcorp to Speak at HRMCon 20261.138Enterprise CISOs and cybersecurity leaders will share real-world lessons for strengthening Workforce Security, advancing Security Behavior Management, and reducing risk across humans and AI agents AUSTIN...
► Artikel lesen
FrDividendenbekanntmachungen (28.08.2026)13.117 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  361 DEGREES INTERNATIONAL LTD  KYG884931042  0,222 HKD  0,0243 EUR  ABC-MART INC  JP3152740001  40 JPY  0,2152 EUR  ADMIE IPTO HOLDING...
► Artikel lesen
FrLABCORP HOLDINGS INC. - 8-K, Current Report2
25.08.Should You Continue to Hold Labcorp Stock in Your Portfolio?4
24.08.Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings301Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and rule out amyloid pathology across specialty and primary care settings Measures phosphorylated...
► Artikel lesen
21.08.Biotech Stocks At 52-Week Highs - Scribe Therapeutics Continues Rise After Nasdaq Debut, Royalty Pharma, Haemonetics, 10x Genomics, Labcorp Holdings625WASHINGTON (dpa-AFX) - The following biotech stocks reached a 52-week high on August 20, 2026, driven by key catalysts such as new product launches and the prospective release of data from clinical...
► Artikel lesen
18.08.Labcorp und NACHC kooperieren zur Förderung von Führungskräften in Gesundheitszentren4
17.08.LABCORP HOLDINGS INC. - 8-K, Current Report3
LABCORP Aktie jetzt für 0€ handeln
14.08.Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics909LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park...
► Artikel lesen
10.08.Is Labcorp Stock a Buy as Growth Improves but Valuation Stays Rich?5
10.08.Labcorp Announces FDA Approval Of PGDx Elio Tissue Complete CDx324WASHINGTON (dpa-AFX) - Labcorp (LH) announced the FDA has approved PGDx elio tissue complete CDx as a companion diagnostic to help identify patients with advanced melanoma with certain BRAF...
► Artikel lesen
10.08.Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma448Labcorp's FDA-approved PGDx elio® tissue complete CDx helps identify advanced melanoma patients with certain BRAF variants eligible for BRAF and BRAF/MEK inhibitor...
► Artikel lesen
04.08.Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer205First FDA-approved IHC assay identifies patients who may be eligible for combination treatment with TRUQAP® (capivasertib) BURLINGTON, N.C., Aug. 4, 2026 /PRNewswire/...
► Artikel lesen
30.07.Labcorp forecasts 2026 adjusted EPS of $18.10-$18.55 as it raises revenue growth outlook to 5.4%-6.3%3
30.07.Labcorp Q2 2026 slides: strong results drive guidance raise6
30.07.Labcorp Q2 2026 slides: revenue rises 5.8%, guidance lifted5
30.07.Labcorp Holdings Inc. Reveals Advance In Q2 Income409WASHINGTON (dpa-AFX) - Labcorp Holdings Inc. (LH) reported a profit for its second quarter that Increases, from the same period last yearThe company's bottom line totaled $298.7 million, or...
► Artikel lesen
30.07.Labcorp Holdings Non-GAAP EPS of $4.99 beats by $0.22, revenue of $3.73B beats by $20M3
30.07.LABCORP HOLDINGS INC. - 8-K, Current Report4
30.07.Labcorp Holdings Inc: Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance329Results from operations for second quarter 2026 versus second quarter 2025: Revenue: $3.73 billion vs. $3.53 billion, up 5.8% Diluted EPS: $3.64 vs. $2.84...
► Artikel lesen
Weiter >>
98 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1